Whether working capital should be a walk-away from regulatory-approval

Situation

Carve-out separation lead in a health-system acquiring a specialty practice has one working extract — regulatory-approval critical-path calendar — after a founder who will not sign a non-compete. If regulatory-approval critical-path calendar cannot support working capital should be, the honest M&A Due Diligence output is hold.

Decision

Carve-out separation lead in a health-system acquiring a specialty practice must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after a founder who will not sign a non-compete.

Hypotheses to test

• Carve-out separation lead can defend Proceed from regulatory-approval critical-path calendar after a founder who will not sign a non-compete in a M&A Due Diligence challenge.
• Carve-out separation lead cannot defend Proceed from regulatory-approval critical-path calendar; Reprice is what the extract actually supports after a founder who will not sign a non-compete.
• A founder who will not sign a non-compete never reached the population in regulatory-approval critical-path calendar — reopen intake, do not close working capital should be.
• Two facts in regulatory-approval critical-path calendar after a founder who will not sign a non-compete conflict for carve-out separation lead; hold this People and Contracts file.

Analysis required

• Name the document carve-out separation lead still needs before signing.
• Test whether a founder who will not sign a non-compete is a diligence gap, a price chip, or a walk-away.
• Separate a one-off add-back from a recurring earnings issue in regulatory-approval critical-path calendar.
• For this M&A Due Diligence People and Contracts file, read regulatory-approval critical-path calendar against a founder who will not sign a non-compete and write the one fact that would move working capital should be for carve-out separation lead.

Recommendation

Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / People and Contracts packet (regulatory-approval critical-path calendar after a founder who will not sign a non-compete). The follow-on People and Contracts action is what carve-out separation lead does next: implement the option, assign an owner, and log the missing fact.